ContextVision ABOSL:CONTX +6.97%81 Market Cap is kr263.0 Mil as of Jun. 29, 2026. GuruFocus rates OSL:CONTX with a GF Score™ of 81/100 and a GF Value™ of kr5.13 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 694 Healthcare Providers & Services companies, ContextVision AB ranks worse than 70.17% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ContextVision AB's share price for the quarter that ended in Mar. 2026 was kr3.44. ContextVision AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 74.8 Mil. Therefore, ContextVision AB's market cap for the quarter that ended in Mar. 2026 was kr257.2 Mil.
ContextVision AB's quarterly market cap
declined
from Sep. 2025 (kr349.1 Mil) to Dec. 2025 (kr319.8 Mil) and
declined
from Dec. 2025 (kr319.8 Mil) to Mar. 2026 (kr257.2 Mil).
ContextVision AB's annual market cap
declined
from Dec. 2023 (kr595.7 Mil) to Dec. 2024 (kr418.7 Mil) and
declined
from Dec. 2024 (kr418.7 Mil) to Dec. 2025 (kr319.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ContextVision AB's Enterprise Value for Today is kr205.0 Mil.
ContextVision AB (OSL:CONTX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ContextVision AB Market Cap Related Terms
ContextVision AB Market Cap Historical Data
* Premium members only.
The historical data trend for ContextVision AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:CONTX vs VEEV, BTSG, TEM: Market Cap Comparison
For the Health Information Services subindustry, ContextVision AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ContextVision AB Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ContextVision AB's Market Cap distribution charts can be found below:
* The bar in red indicates where ContextVision AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ContextVision AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ContextVision AB (OSL:CONTX) has a Market Cap of kr263.0 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ContextVision AB and its competitors. According to the industry distribution chart, ContextVision AB ranks #487 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 70.2%.
Is ContextVision AB's Market Cap too high?
ContextVision AB's current Market Cap is kr263.0 Mil. Based on the distribution chart, ContextVision AB ranks #487 out of 694 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, ContextVision AB has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ContextVision AB's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, ContextVision AB ranks #487 out of 694 companies for Market Cap. This places ContextVision AB in the lower half of its industry. The industry median Market Cap is 93.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.08, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ContextVision AB and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ContextVision AB's current Market Cap is kr263.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ContextVision AB stock overvalued right now?
Based on GuruFocus' analysis, ContextVision AB (OSL:CONTX) is currently considered Significantly Undervalued. The stock's GF Value™ is kr5.13, compared to a current price of kr3.53 — trading 31.2% below its estimated fair value. The current Market Cap is kr263.0 Mil. ContextVision AB's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For ContextVision AB (OSL:CONTX), the current Market Cap is kr263.0 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ContextVision AB (OSL:CONTX) Overvalued in 2026?
Based on GuruFocus' analysis, ContextVision AB stock appears to be undervalued.
The current stock price of kr3.53 is trading 31.2% below its estimated GF Value™ of kr5.13.
GuruFocus considers ContextVision AB to be Significantly Undervalued.
Key valuation signals for OSL:CONTX:
Market Cap: kr263.0 Mil
GF Value™: kr5.13 vs. price of kr3.53 (31.2% below fair value)
No single metric tells the full story. See the OSL:CONTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ContextVision AB is a medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. Its geographical segments are Asia, Europe, and America.
81GF Score
Get the complete analysis for OSL:CONTX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:CONTX has been successfully added to your 
